Cubist Pharmaceuticals, Inc. (NASDAQ:CBST)
|
22.81 +0.10 (0.44%) Mar 17 - Close |
|
|
|
- Compare CBST with:
- View: Line | Candlestick
Company Profile
Cubist Pharmaceuticals, Inc.
65 Hayden Avenue
Lexington, MA 02421
United States - Map
Phone: (781) 860-8660
Fax: (781) 861-0566
Website: www.cubist.com
State of incorporation: Delaware
CEO: Michael W. Bonney
Employees: 600
Sector: Healthcare
Industry Group: Drugs
Industry: Drug Manufacturers - Other
A biopharmaceutical company
A biopharmaceutical company, which is focused on the research, development and commercialization of pharmaceutical products that address unmet medical needs in the acute care environment.
Recent news for CBST
-
Business Wire - Mar 15 at 1:30PM (EST)
-
CUBIST PHARMACEUTICALS INC Financials
EDGAR Online Financials - Mar 05 at 1:04PM (EST)
-
Seeking Alpha - Mar 02 at 2:46PM (EST)
-
Top Stocks Show Strong Action As Uptrend Returns
Investor's Business Daily, Inc. - Mar 01 at 6:13PM (EST)
-
- Mar 01 at 6:13PM (EST)
-
Biotech Stocks: M&A bids stoke biotech stocks
MarketWatch - Mar 01 at 4:07PM (EST)
-
CUBIST PHARMACEUTICALS INC Files SEC form 8-K/A, Financial Statements and Exhibits
EDGAR Online - Feb 26 at 5:29PM (EST)
-
CUBIST PHARMACEUTICALS INC Files SEC form 10-K, Annual Report
EDGAR Online - Feb 26 at 4:13PM (EST)
-
Zacks.com - Feb 26 at 8:37AM (EST)
-
Evotec Extends and Broadens Research Agreement With Cubist Pharmaceuticals
GlobeNewswire - Feb 25 at 2:07AM (EST)
Member sentiment (?) Neutral
Top members owning CBST
-
Top 44%
+1.36%
-
Top 39%
+1.98%
-
Top 25%
+4.03%
* Average monthly return vs. S&P 500